Delivery Order SPE2DB20D1004-SPE2DB25FNKMX
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order valued at $95,223.63 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive, open-market award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,756.45 by the Defense Logistics Agency on September 4, 2025, for the supply of Eliquis 5 mg tablets (60-count units). The contract is classified as a non-set-aside award with firm fixed-price terms and an ultimate completion date of September 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on August 13, 2025, for Eliquis 5 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,815.81 and is set to be completed by August 14, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order from the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Eliquis 2.5 mg tablets (60 count) with a contract value of $7,862.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract represents a single order fulfillment under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 60 tablets of Eliquis 5 mg, valued at $5,817.26. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed-price pricing with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract has a ceiling value of $6,349.14 and carries no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,698.09 by the Defense Logistics Agency on July 31, 2025, for the supply of Eliquis 5 mg tablets (60-count). The award utilizes a firm fixed-price contract structure with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,156.88 by the Defense Logistics Agency Medical Supply Chain on July 25, 2025, for the supply of Eliquis 5 mg tablets (60-count). The contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $27,225.53 on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKMXDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets in quantities of 60s, with a ceiling value of $12,825.81. The contract is classified as a Firm Fixed Price delivery order with an ultimate completion date of September 5, 2025, and was competitively awarded without a set-aside designation. The product will be sourced from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters and primary distribution operations. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The current award for Eliquis, an anticoagulant medication commonly used in military and veteran healthcare settings, represents one of numerous delivery orders executed under this strategic contract vehicle, which supports customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 9/4/25 |